BlackRock Inc. - ACURX PHARMACEUTICALS INC ownership

ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 10 filers reported holding ACURX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ACURX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$27,189
-45.6%
18,126
-4.0%
0.00%
Q2 2023$50,019
-10.5%
18,875
+16.8%
0.00%
Q1 2023$55,917
-10.2%
16,161
+3.3%
0.00%
Q4 2022$62,243
+32.4%
15,639
+0.6%
0.00%
Q3 2022$47,000
-23.0%
15,549
-2.7%
0.00%
Q2 2022$61,000
+10.9%
15,984
-4.3%
0.00%
Q1 2022$55,000
+89.7%
16,699
+149.8%
0.00%
Q4 2021$29,000
-12.1%
6,685
+2.6%
0.00%
Q3 2021$33,0006,5150.00%
Other shareholders
ACURX PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Draper Asset Management, LLC 266,025$873,0000.72%
Patriot Financial Group Insurance Agency, LLC 9,750$32,0000.01%
Semmax Financial Advisors Inc. 1,263$4,0000.00%
TD Waterhouse Canada Inc. 30,000$102,3000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,941$35,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 10,100$33,0000.00%
BlackRock Inc. 16,699$55,0000.00%
Tower Research Capital LLC (TRC) 3,319$11,0000.00%
WELLS FARGO & COMPANY/MN 16$00.00%
View complete list of ACURX PHARMACEUTICALS INC shareholders